Compounds > n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid
Page last updated: 2024-08-23

n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid and Disease Models, Animal

n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid has been researched along with Disease Models, Animal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jarrett, SG; Liang, LP; Patel, M1
Bergeron, RJ; Brittenham, GM; Wiegand, J1

Other Studies

2 other study(ies) available for n,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid and Disease Models, Animal

ArticleYear
Chelation of mitochondrial iron prevents seizure-induced mitochondrial dysfunction and neuronal injury.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Nov-05, Volume: 28, Issue:45

    Topics: Analysis of Variance; Animals; Behavior, Animal; Bleomycin; Chelating Agents; Colorimetry; Disease Models, Animal; DNA, Mitochondrial; Edetic Acid; Fluoresceins; Glutathione; Glutathione Disulfide; Hippocampus; Iron; Kainic Acid; Male; Mitochondrial Diseases; Organic Chemicals; Rats; Rats, Sprague-Dawley; Status Epilepticus; Subcellular Fractions; Time Factors

2008
HBED ligand: preclinical studies of a potential alternative to deferoxamine for treatment of chronic iron overload and acute iron poisoning.
    Blood, 2002, Apr-15, Volume: 99, Issue:8

    Topics: Acute Disease; Animals; Blood Pressure; Cebus; Chronic Disease; Deferoxamine; Disease Models, Animal; Dogs; Drug Administration Routes; Drug Evaluation, Preclinical; Edetic Acid; Heart Rate; Iron; Iron Chelating Agents; Iron Overload; Male; Poisoning; Rats; Rats, Sprague-Dawley; Therapeutic Equivalency

2002